Barclays Maintains Overweight on Incyte, Raises Price Target to $143
Benzinga Newsdesk 21 hours ago
Analyst RatingsNewsPrice Target
Barclays analyst Etzer Darout maintains Incyte (NASDAQ:INCY) with a Overweight and raises the price target from $139 to $143.
Barclays analyst Etzer Darout maintains Incyte (NASDAQ:INCY) with a Overweight and raises the price target from $139 to $143.